;

Home >>

Global Pharmacovigilance and Drug Safety Software Market Report 2020 by Key Players Types Applications Countries Market Size Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)

Published: Sep-2020 | Format: PDF | Maia Research | Number of pages: 125 | Code: MRS - 774071

The Pharmacovigilance and Drug Safety Software market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Pharmacovigilance and Drug Safety Software market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Pharmacovigilance and Drug Safety Software market. The report focuses on well-known providers in the global Pharmacovigilance and Drug Safety Software industry, market segments, competition, and the macro environment.

Under COVID-19 Outbreak, how the Pharmacovigilance and Drug Safety Software Industry will develop is also analyzed in detail in Chapter 1.7 of the report.
In Chapter 2.4, we analyzed industry trends in the context of COVID-19.
In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets.
In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries.
In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out.

A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players.

Key players in the global Pharmacovigilance and Drug Safety Software market covered in Chapter 4:
Ennov Solutions Inc.
Sarjen Systems Pvt. Ltd
EXTEDO GmbH
Sparta Systems, Inc.
Online Business Applications, Inc.
United BioSource Corporation
Oracle Corporation
ArisGlobal

In Chapter 11 and 13.3, on the basis of types, the Pharmacovigilance and Drug Safety Software market from 2015 to 2026 is primarily split into:
Adverse Event Reporting Software
Drug Safety Audits Software
Issue Tracking Software
Fully Integrated Software

In Chapter 12 and 13.4, on the basis of applications, the Pharmacovigilance and Drug Safety Software market from 2015 to 2026 covers:
Pharma and Biotech Companies
Contract Research Organizations (CROs)
Business Process Outsourcing (BPO) Firms
Other Pharmacovigilance Service Providers

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:
North America (Covered in Chapter 6 and 13)
United States
Canada
Mexico
Europe (Covered in Chapter 7 and 13)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8 and 13)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 9 and 13)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 10 and 13)
Brazil
Argentina
Columbia
Chile
Others

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2026
Table of Content

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Regulatory Scenario by Region/Country
1.4 Market Investment Scenario Strategic
1.5 Market Analysis by Type
1.5.1 Global Pharmacovigilance and Drug Safety Software Market Share by Type (2020-2026)
1.5.2 Adverse Event Reporting Software
1.5.3 Drug Safety Audits Software
1.5.4 Issue Tracking Software
1.5.5 Fully Integrated Software
1.6 Market by Application
1.6.1 Global Pharmacovigilance and Drug Safety Software Market Share by Application (2020-2026)
1.6.2 Pharma and Biotech Companies
1.6.3 Contract Research Organizations (CROs)
1.6.4 Business Process Outsourcing (BPO) Firms
1.6.5 Other Pharmacovigilance Service Providers
1.7 Pharmacovigilance and Drug Safety Software Industry Development Trends under COVID-19 Outbreak
1.7.1 Global COVID-19 Status Overview
1.7.2 Influence of COVID-19 Outbreak on Pharmacovigilance and Drug Safety Software Industry Development

2. Global Market Growth Trends
2.1 Industry Trends
2.1.1 SWOT Analysis
2.1.2 Porter’s Five Forces Analysis
2.2 Potential Market and Growth Potential Analysis
2.3 Industry News and Policies by Regions
2.3.1 Industry News
2.3.2 Industry Policies
2.4 Industry Trends Under COVID-19

3 Value Chain of Pharmacovigilance and Drug Safety Software Market
3.1 Value Chain Status
3.2 Pharmacovigilance and Drug Safety Software Manufacturing Cost Structure Analysis
3.2.1 Production Process Analysis
3.2.2 Manufacturing Cost Structure of Pharmacovigilance and Drug Safety Software
3.2.3 Labor Cost of Pharmacovigilance and Drug Safety Software
3.2.3.1 Labor Cost of Pharmacovigilance and Drug Safety Software Under COVID-19
3.3 Sales and Marketing Model Analysis
3.4 Downstream Major Customer Analysis (by Region)
3.5 Value Chain Status Under COVID-19

4 Players Profiles
4.1 Ennov Solutions Inc.
4.1.1 Ennov Solutions Inc. Basic Information
4.1.2 Pharmacovigilance and Drug Safety Software Product Profiles, Application and Specification
4.1.3 Ennov Solutions Inc. Pharmacovigilance and Drug Safety Software Market Performance (2015-2020)
4.1.4 Ennov Solutions Inc. Business Overview
4.2 Sarjen Systems Pvt. Ltd
4.2.1 Sarjen Systems Pvt. Ltd Basic Information
4.2.2 Pharmacovigilance and Drug Safety Software Product Profiles, Application and Specification
4.2.3 Sarjen Systems Pvt. Ltd Pharmacovigilance and Drug Safety Software Market Performance (2015-2020)
4.2.4 Sarjen Systems Pvt. Ltd Business Overview
4.3 EXTEDO GmbH
4.3.1 EXTEDO GmbH Basic Information
4.3.2 Pharmacovigilance and Drug Safety Software Product Profiles, Application and Specification
4.3.3 EXTEDO GmbH Pharmacovigilance and Drug Safety Software Market Performance (2015-2020)
4.3.4 EXTEDO GmbH Business Overview
4.4 Sparta Systems, Inc.
4.4.1 Sparta Systems, Inc. Basic Information
4.4.2 Pharmacovigilance and Drug Safety Software Product Profiles, Application and Specification
4.4.3 Sparta Systems, Inc. Pharmacovigilance and Drug Safety Software Market Performance (2015-2020)
4.4.4 Sparta Systems, Inc. Business Overview
4.5 Online Business Applications, Inc.
4.5.1 Online Business Applications, Inc. Basic Information
4.5.2 Pharmacovigilance and Drug Safety Software Product Profiles, Application and Specification
4.5.3 Online Business Applications, Inc. Pharmacovigilance and Drug Safety Software Market Performance (2015-2020)
4.5.4 Online Business Applications, Inc. Business Overview
4.6 United BioSource Corporation
4.6.1 United BioSource Corporation Basic Information
4.6.2 Pharmacovigilance and Drug Safety Software Product Profiles, Application and Specification
4.6.3 United BioSource Corporation Pharmacovigilance and Drug Safety Software Market Performance (2015-2020)
4.6.4 United BioSource Corporation Business Overview
4.7 Oracle Corporation
4.7.1 Oracle Corporation Basic Information
4.7.2 Pharmacovigilance and Drug Safety Software Product Profiles, Application and Specification
4.7.3 Oracle Corporation Pharmacovigilance and Drug Safety Software Market Performance (2015-2020)
4.7.4 Oracle Corporation Business Overview
4.8 ArisGlobal
4.8.1 ArisGlobal Basic Information
4.8.2 Pharmacovigilance and Drug Safety Software Product Profiles, Application and Specification
4.8.3 ArisGlobal Pharmacovigilance and Drug Safety Software Market Performance (2015-2020)
4.8.4 ArisGlobal Business Overview

5 Global Pharmacovigilance and Drug Safety Software Market Analysis by Regions
5.1 Global Pharmacovigilance and Drug Safety Software Sales, Revenue and Market Share by Regions
5.1.1 Global Pharmacovigilance and Drug Safety Software Sales by Regions (2015-2020)
5.1.2 Global Pharmacovigilance and Drug Safety Software Revenue by Regions (2015-2020)
5.2 North America Pharmacovigilance and Drug Safety Software Sales and Growth Rate (2015-2020)
5.3 Europe Pharmacovigilance and Drug Safety Software Sales and Growth Rate (2015-2020)
5.4 Asia-Pacific Pharmacovigilance and Drug Safety Software Sales and Growth Rate (2015-2020)
5.5 Middle East and Africa Pharmacovigilance and Drug Safety Software Sales and Growth Rate (2015-2020)
5.6 South America Pharmacovigilance and Drug Safety Software Sales and Growth Rate (2015-2020)

6 North America Pharmacovigilance and Drug Safety Software Market Analysis by Countries
6.1 North America Pharmacovigilance and Drug Safety Software Sales, Revenue and Market Share by Countries
6.1.1 North America Pharmacovigilance and Drug Safety Software Sales by Countries (2015-2020)
6.1.2 North America Pharmacovigilance and Drug Safety Software Revenue by Countries (2015-2020)
6.1.3 North America Pharmacovigilance and Drug Safety Software Market Under COVID-19
6.2 United States Pharmacovigilance and Drug Safety Software Sales and Growth Rate (2015-2020)
6.2.1 United States Pharmacovigilance and Drug Safety Software Market Under COVID-19
6.3 Canada Pharmacovigilance and Drug Safety Software Sales and Growth Rate (2015-2020)
6.4 Mexico Pharmacovigilance and Drug Safety Software Sales and Growth Rate (2015-2020)

7 Europe Pharmacovigilance and Drug Safety Software Market Analysis by Countries
7.1 Europe Pharmacovigilance and Drug Safety Software Sales, Revenue and Market Share by Countries
7.1.1 Europe Pharmacovigilance and Drug Safety Software Sales by Countries (2015-2020)
7.1.2 Europe Pharmacovigilance and Drug Safety Software Revenue by Countries (2015-2020)
7.1.3 Europe Pharmacovigilance and Drug Safety Software Market Under COVID-19
7.2 Germany Pharmacovigilance and Drug Safety Software Sales and Growth Rate (2015-2020)
7.2.1 Germany Pharmacovigilance and Drug Safety Software Market Under COVID-19
7.3 UK Pharmacovigilance and Drug Safety Software Sales and Growth Rate (2015-2020)
7.3.1 UK Pharmacovigilance and Drug Safety Software Market Under COVID-19
7.4 France Pharmacovigilance and Drug Safety Software Sales and Growth Rate (2015-2020)
7.4.1 France Pharmacovigilance and Drug Safety Software Market Under COVID-19
7.5 Italy Pharmacovigilance and Drug Safety Software Sales and Growth Rate (2015-2020)
7.5.1 Italy Pharmacovigilance and Drug Safety Software Market Under COVID-19
7.6 Spain Pharmacovigilance and Drug Safety Software Sales and Growth Rate (2015-2020)
7.6.1 Spain Pharmacovigilance and Drug Safety Software Market Under COVID-19
7.7 Russia Pharmacovigilance and Drug Safety Software Sales and Growth Rate (2015-2020)
7.7.1 Russia Pharmacovigilance and Drug Safety Software Market Under COVID-19

8 Asia-Pacific Pharmacovigilance and Drug Safety Software Market Analysis by Countries
8.1 Asia-Pacific Pharmacovigilance and Drug Safety Software Sales, Revenue and Market Share by Countries
8.1.1 Asia-Pacific Pharmacovigilance and Drug Safety Software Sales by Countries (2015-2020)
8.1.2 Asia-Pacific Pharmacovigilance and Drug Safety Software Revenue by Countries (2015-2020)
8.1.3 Asia-Pacific Pharmacovigilance and Drug Safety Software Market Under COVID-19
8.2 China Pharmacovigilance and Drug Safety Software Sales and Growth Rate (2015-2020)
8.2.1 China Pharmacovigilance and Drug Safety Software Market Under COVID-19
8.3 Japan Pharmacovigilance and Drug Safety Software Sales and Growth Rate (2015-2020)
8.3.1 Japan Pharmacovigilance and Drug Safety Software Market Under COVID-19
8.4 South Korea Pharmacovigilance and Drug Safety Software Sales and Growth Rate (2015-2020)
8.4.1 South Korea Pharmacovigilance and Drug Safety Software Market Under COVID-19
8.5 Australia Pharmacovigilance and Drug Safety Software Sales and Growth Rate (2015-2020)
8.6 India Pharmacovigilance and Drug Safety Software Sales and Growth Rate (2015-2020)
8.6.1 India Pharmacovigilance and Drug Safety Software Market Under COVID-19
8.7 Southeast Asia Pharmacovigilance and Drug Safety Software Sales and Growth Rate (2015-2020)
8.7.1 Southeast Asia Pharmacovigilance and Drug Safety Software Market Under COVID-19

9 Middle East and Africa Pharmacovigilance and Drug Safety Software Market Analysis by Countries
9.1 Middle East and Africa Pharmacovigilance and Drug Safety Software Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Pharmacovigilance and Drug Safety Software Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Pharmacovigilance and Drug Safety Software Revenue by Countries (2015-2020)
9.1.3 Middle East and Africa Pharmacovigilance and Drug Safety Software Market Under COVID-19
9.2 Saudi Arabia Pharmacovigilance and Drug Safety Software Sales and Growth Rate (2015-2020)
9.3 UAE Pharmacovigilance and Drug Safety Software Sales and Growth Rate (2015-2020)
9.4 Egypt Pharmacovigilance and Drug Safety Software Sales and Growth Rate (2015-2020)
9.5 Nigeria Pharmacovigilance and Drug Safety Software Sales and Growth Rate (2015-2020)
9.6 South Africa Pharmacovigilance and Drug Safety Software Sales and Growth Rate (2015-2020)

10 South America Pharmacovigilance and Drug Safety Software Market Analysis by Countries
10.1 South America Pharmacovigilance and Drug Safety Software Sales, Revenue and Market Share by Countries
10.1.1 South America Pharmacovigilance and Drug Safety Software Sales by Countries (2015-2020)
10.1.2 South America Pharmacovigilance and Drug Safety Software Revenue by Countries (2015-2020)
10.1.3 South America Pharmacovigilance and Drug Safety Software Market Under COVID-19
10.2 Brazil Pharmacovigilance and Drug Safety Software Sales and Growth Rate (2015-2020)
10.2.1 Brazil Pharmacovigilance and Drug Safety Software Market Under COVID-19
10.3 Argentina Pharmacovigilance and Drug Safety Software Sales and Growth Rate (2015-2020)
10.4 Columbia Pharmacovigilance and Drug Safety Software Sales and Growth Rate (2015-2020)
10.5 Chile Pharmacovigilance and Drug Safety Software Sales and Growth Rate (2015-2020)

11 Global Pharmacovigilance and Drug Safety Software Market Segment by Types
11.1 Global Pharmacovigilance and Drug Safety Software Sales, Revenue and Market Share by Types (2015-2020)
11.1.1 Global Pharmacovigilance and Drug Safety Software Sales and Market Share by Types (2015-2020)
11.1.2 Global Pharmacovigilance and Drug Safety Software Revenue and Market Share by Types (2015-2020)
11.2 Adverse Event Reporting Software Sales and Price (2015-2020)
11.3 Drug Safety Audits Software Sales and Price (2015-2020)
11.4 Issue Tracking Software Sales and Price (2015-2020)
11.5 Fully Integrated Software Sales and Price (2015-2020)

12 Global Pharmacovigilance and Drug Safety Software Market Segment by Applications
12.1 Global Pharmacovigilance and Drug Safety Software Sales, Revenue and Market Share by Applications (2015-2020)
12.1.1 Global Pharmacovigilance and Drug Safety Software Sales and Market Share by Applications (2015-2020)
12.1.2 Global Pharmacovigilance and Drug Safety Software Revenue and Market Share by Applications (2015-2020)
12.2 Pharma and Biotech Companies Sales, Revenue and Growth Rate (2015-2020)
12.3 Contract Research Organizations (CROs) Sales, Revenue and Growth Rate (2015-2020)
12.4 Business Process Outsourcing (BPO) Firms Sales, Revenue and Growth Rate (2015-2020)
12.5 Other Pharmacovigilance Service Providers Sales, Revenue and Growth Rate (2015-2020)

13 Pharmacovigilance and Drug Safety Software Market Forecast by Regions (2020-2026)
13.1 Global Pharmacovigilance and Drug Safety Software Sales, Revenue and Growth Rate (2020-2026)
13.2 Pharmacovigilance and Drug Safety Software Market Forecast by Regions (2020-2026)
13.2.1 North America Pharmacovigilance and Drug Safety Software Market Forecast (2020-2026)
13.2.2 Europe Pharmacovigilance and Drug Safety Software Market Forecast (2020-2026)
13.2.3 Asia-Pacific Pharmacovigilance and Drug Safety Software Market Forecast (2020-2026)
13.2.4 Middle East and Africa Pharmacovigilance and Drug Safety Software Market Forecast (2020-2026)
13.2.5 South America Pharmacovigilance and Drug Safety Software Market Forecast (2020-2026)
13.3 Pharmacovigilance and Drug Safety Software Market Forecast by Types (2020-2026)
13.4 Pharmacovigilance and Drug Safety Software Market Forecast by Applications (2020-2026)
13.5 Pharmacovigilance and Drug Safety Software Market Forecast Under COVID-19

14 Appendix
14.1 Methodology
14.2 Research Data Source


                        
            

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)3400 View Pricing